Role of nurses in medication management at the end of life: a qualitative interview study

Autor: Bregje A. A. Huisman, Eric C. T. Geijteman, Marianne K. Dees, Noralie N. Schonewille, Margriet Wieles, Lia van Zuylen, Karolina M. Szadek, Agnes van der Heide

Publikováno v: BMC Palliative Care, Vol 19, Iss 1, Pp 1-11 (2020)

Abstract Background Patients in the last phase of their lives often use many medications. Physicians tend to lack awareness that reviewing the usefulness of medication at the end of patients’ lives is important. The aim of this study is to gain ins

Externí odkaz: https://doaj.org/article/a02257db7eac479ea37fee13100c556e

Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life:The SILENCE Randomized Clinical Trial

Autor: Agnes van der Heide, Renske Boogaard, Carin C.D. van der Rijt, Heike S. Noordzij-Nooteboom, Eric C T Geijteman, Lia van Zuylen, Bregje A. A. Huisman, Harriëtte J. van Esch, Esther Oomen-de Hoop

Publikováno v: van Esch, H J, van Zuylen, L, Geijteman, E C T, Oomen-de Hoop, E, Huisman, B A A, Noordzij-Nooteboom, H S, Boogaard, R, van der Heide, A & van der Rijt, C C D 2021, ' Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life : The SILENCE Randomized Clinical Trial ', JAMA, vol. 326, no. 13, pp. 1268-1276 . https://doi.org/10.1001/jama.2021.14785
JAMA-Journal of the American Medical Association, 326(13), 1268-1276. American Medical Association
JAMA, 326(13), 1268-1276. American Medical Association

Importance Death rattle, defined as noisy breathing caused by the presence of mucus in the respiratory tract, is relatively common among dying patients. Although clinical guidelines recommend anticholinergic drugs to reduce the death rattle after non

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30a649b2886a852194144a9ea0a2cd0
https://research.vumc.nl/en/publications/459562d7-ff6a-42fb-a031-c6e94da3fa90

Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy

Autor: Lia van Zuylen, Karolina M. Szadek, Bregje A. A. Huisman, Nathalie Kolf, Agnes van der Heide, Monique A. H. Steegers, Marianne Dees, Eric C T Geijteman

Publikováno v: Seminars in Thrombosis and Hemostasis, 47, 6, pp. 735-744
Huisman, B A A, Geijteman, E C T, Kolf, N, Dees, M K, van Zuylen, L, Szadek, K M, Steegers, M A H & van der Heide, A 2021, ' Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy ', Seminars in Thrombosis and Hemostasis, vol. 47, no. 6, pp. 735-744 . https://doi.org/10.1055/s-0041-1725115
Seminars in Thrombosis and Hemostasis, 47(06), 735-744. Thieme Medical Publishers
Seminars in Thrombosis and Hemostasis, 47, 735-744
Seminars in Thrombosis and Hemostasis, 47(6), 735-744. Thieme Medical Publishers

Contains fulltext : 238058.pdf (Publisher’s version ) (Closed access) Patients with a limited life expectancy have an increased risk of thromboembolic and bleeding complications. Anticoagulants are often continued until death, independent of their

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6f9e80638d3bc74d7915cf1cafb359
https://pubmed.ncbi.nlm.nih.gov/33971680

Medication Discontinuation at the End of Life: A Questionnaire Study on Physicians' Experiences and Opinions

Autor: Roberto S.G.M. Perez, Lia van Zuylen, Carin C.D. van der Rijt, Marianne Dees, Eric C T Geijteman, Agnes van der Heide, Bregje A. A. Huisman

Publikováno v: Geijteman, E C T, Huisman, B A A, Dees, M K, Perez, R S G M, van der Rijt, C C D, van Zuylen, L & van der Heide, A 2018, ' Medication Discontinuation at the End of Life: A Questionnaire Study on Physicians' Experiences and Opinions ', Journal of Palliative Medicine, vol. 21, no. 8, pp. 1166-1170 . https://doi.org/10.1089/jpm.2017.0501
Journal of Palliative Medicine, 21, 8, pp. 1166-1170
Journal of Palliative Medicine, 21(8), 1166-1170. Mary Ann Liebert Inc.
Journal of Palliative Medicine, 21, 1166-1170

Background: Many patients who are in the last phase of life use multiple medications that are continued until shortly before they ultimately die. Little is known about physicians' opinions and experiences regarding medication discontinuation at the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a01fb7a3a4d965edef18d63c810e316
https://doi.org/10.1089/jpm.2017.0501

Perspectives of patients, close relatives, nurses, and physicians on end-of-life medication management

Autor: Marianne Dees, Eric C T Geijteman, Bregje A. A. Huisman, Agnes van der Heide, Evert van Leeuwen, Roberto S.G.M. Perez, Lia van Zuylen, Wim Dekkers

Publikováno v: Palliative & Supportive Care, 16, 580-589
Palliative & Supportive Care, 16(5), 580-589. Cambridge University Press
Palliative & Supportive Care, 16, 5, pp. 580-589
Dees, M K, Geijteman, E C T, Dekkers, W J M, Huisman, B A A, Perez, R S G M, van Zuylen, L, van der Heide, A & van Leeuwen, E 2018, ' Perspectives of patients, close relatives, nurses, and physicians on end-of-life medication management ', Palliative and Supportive Care, vol. 16, no. 5, pp. 580-589 . https://doi.org/10.1017/S1478951517000761

Objective:Our aim was to gain insight into the perspectives of patients, close relatives, nurses, and physicians on medication management for patients with a life expectancy of less than 3 months.Method:We conducted an empirical multicenter study wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32dd3424eab8a46de6e7b53514b7788d
https://doi.org/10.1017/S1478951517000761